🔗 Share this article

Texas Attorney General Ken Paxton is filing a lawsuit against the manufacturers of Tylenol, claiming the companies hid alleged dangers that the pain reliever presented to pediatric neurological development.

This legal action follows four weeks after Donald Trump advocated an unproven link between consuming Tylenol - referred to as paracetamol - throughout gestation and autism spectrum disorder in young ones.

Paxton is taking legal action against the pharmaceutical giant, which once produced the drug, the sole analgesic approved for women during pregnancy, and the current manufacturer, which currently produces it.

In a official comment, he claimed they "misled consumers by gaining financially from suffering and pushing pills regardless of the dangers."

The manufacturer says there is lacking scientific proof linking acetaminophen to autism spectrum disorder.

"These manufacturers misled for generations, knowingly endangering numerous people to line their pockets," the attorney general, from the Republican party, said.

Kenvue stated officially that it was "deeply concerned by the perpetuation of misinformation on the security of acetaminophen and the potential impact that could have on the welfare of US mothers and children."

On its official site, Kenvue also mentioned it had "continuously evaluated the pertinent research and there is no credible data that shows a proven link between taking paracetamol and autism spectrum disorder."

Organizations speaking for medical professionals and medical practitioners agree.

The American College of Obstetricians and Gynecologists has stated paracetamol - the key substance in acetaminophen - is among limited choices for women during pregnancy to manage discomfort and elevated temperature, which can pose major wellness concerns if left untreated.

"In more than two decades of research on the use of paracetamol in gestation, zero credible investigations has definitively established that the use of paracetamol in any period of gestation leads to neurodevelopmental disorders in children," the group said.

This legal action references current declarations from the Trump administration in claiming the medication is reportedly hazardous.

In recent weeks, the former president raised alarms from health experts when he advised pregnant women to "resist strongly" not to take Tylenol when sick.

The US Food and Drug Administration then released a statement that physicians should think about restricting the consumption of Tylenol, while also mentioning that "a causal relationship" between the medication and autism spectrum disorder in children has not been proven.

Health Secretary RFK Jr, who oversees the FDA, had promised in spring to undertake "extensive scientific investigation" that would establish the origin of autism in a short period.

But specialists cautioned that discovering a sole reason of autism - believed by scientists to be the outcome of a complicated interplay of genetic and external influences - would prove challenging.

Autism is a type of lifelong neurodivergence and impairment that impacts how persons perceive and interact with the surroundings, and is identified using physician assessments.

In his legal document, the attorney general - who supports Trump who is seeking the Senate - alleges Kenvue and J&J "deliberately disregarded and sought to suppress the research" around acetaminophen and autism.

The lawsuit attempts to require the companies "remove any marketing or advertising" that states acetaminophen is secure for pregnant women.

This legal action echoes the concerns of a collection of guardians of children with autism and ADHD who sued the producers of Tylenol in two years ago.

The court threw out the legal action, declaring research from the parents' expert witnesses was lacking definitive proof.